Outcome of Antibody‐Mediated Fetal Heart Disease With Standardized Anti‐Inflammatory Transplacental Treatment

Outcome of Antibody‐Mediated Fetal Heart Disease With Standardized Anti‐Inflammatory Transplacental Treatment

Background Transplacental fetal treatment of immune‐mediated fetal heart disease, including third‐degree atrioventricular block (AVB III) and endocardial fibroelastosis, is controversial. Methods and Results To study the impact of routine transplacental fetal treatment, we reviewed 130 consecutive c...

Full description

Bibliographic Details
Main Authors: Wadi Mawad, Lisa Hornberger, Bettina Cuneo, Marie‐Josée Raboisson, Anita J. Moon‐Grady, Jane Lougheed, Karim Diab, Julia Parkman, Earl Silverman, Edgar Jaeggi
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiomyopathy
fetal
heart block
outcome
steroids
treatment
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.023000

Similar Items

Similar Items